DHS 107.10(5)(a)(a) The pharmacist shall review the drug therapy before each prescription is filled or delivered to an MA recipient. The review shall include screening for potential drug therapy problems including therapeutic duplication, drug–disease contraindications, drug–drug interactions, including serious interactions with non-legend drugs, incorrect drug dosage or duration of drug treatment, drug–allergy interactions and clinical abuse or misuse.
DHS 107.10(5)(b)(b) The pharmacist shall offer to discuss with each MA recipient, the recipient’s legal representative or the recipient’s caregiver who presents the prescription, matters which, in the exercise of the pharmacist’s professional judgment and consistent with state statutes and rules governing provisions of this information, the pharmacist deems significant, including the following:
DHS 107.10(5)(b)1.1. The name and description of the medication;
DHS 107.10(5)(b)2.2. The route, dosage form, dosage, route of administration, and duration of drug therapy;
DHS 107.10(5)(b)3.3. Specific directions and precautions for preparation, administration and use by the patient;
DHS 107.10(5)(b)4.4. Common severe side effects or adverse effects or interactions and therapeutic contraindications that may be encountered, including how to avoid them, and the action required if they occur;
DHS 107.10(5)(b)5.5. Techniques for self-monitoring drug therapy;
DHS 107.10(5)(b)6.6. Proper storage;
DHS 107.10(5)(b)7.7. Prescription refill information; and
DHS 107.10(5)(b)8.8. Action to be taken in the event of a missed dose.
DHS 107.10(5)(c)(c) The pharmacist shall make a reasonable effort to obtain, record and maintain at least the following information regarding each MA recipient for whom the pharmacist dispenses drugs under the MA program:
DHS 107.10(5)(c)1.1. The individual’s name, address, telephone number, date of birth or age and gender;
DHS 107.10(5)(c)2.2. The individual’s history where significant, including any disease state or states, known allergies and drug reactions, and a comprehensive list of medications and relevant devices; and
DHS 107.10(5)(c)3.3. The pharmacist’s comments relevant to the individual’s drug therapy.
DHS 107.10(5)(d)(d) Nothing in this subsection shall be construed as requiring a pharmacist to provide consultation when an MA recipient, the recipient’s legal representative or the recipient’s caregiver refuses the consultation.
DHS 107.10 HistoryHistory: Cr. Register, February, 1986, No. 362, eff. 3-1-86; am. (3) (h), Register, February, 1988, No. 386, eff. 3-1-88; emerg. am. (2) (e) and (f), (4) (k), cr. (2) (g), (3) (j) and (k), (4) (L), eff. 4-27-91; r. and recr. Register, December, 1991, No. 432, eff. 1-1-92, r. and recr. (2) (c), am. (2) (d) and (e), cr. (2) (f) and (g), (3) (L) and (4) (n) to (t), Register, January, 1997, No. 493, eff. 2-1-97; CR 03-033: am. (1), (2) (d), (3) (b) to (d), (h) (intro.), (i), (4) (L) and (5) (a), r. (2) (a), cr. (3) (h) 8. Register December 2003 No. 576, eff. 1-1-04; correction in (1) made under s. 13.92 (4) (b)7., Stats., Register February 2014 No. 698; 2021 Wis. Act 125: am. (2) (c) Register February 2022 No. 794, eff. 2-6-22.
DHS 107.11DHS 107.11Home health services.
DHS 107.11(1)(1)Definitions. In this section:
DHS 107.11(1)(a)(a) “Community-based residential facility” has the meaning prescribed in s. 50.01 (1g), Stats.
DHS 107.11(1)(b)(b) “Home health aide services” means medically oriented tasks, assistance with activities of daily living and incidental household tasks required to facilitate treatment of a recipient’s medical condition or to maintain the recipient’s health.
DHS 107.11(1)(c)(c) “Home health visit” or “visit” means a period of time of any duration during which home health services are provided through personal contact by agency personnel of less than 8 hours a day in the recipient’s place of residence for the purpose of providing a covered home health service. The services are provided by a home health provider employed by a home health agency, by a home health provider under contract to a home health agency according to the requirements of s. DHS 133.19 or by arrangement with a home health agency. A visit begins when the home health provider starts to provide a covered service and ends when the service is complete.
DHS 107.11(1)(d)(d) “Home health provider” means a person who is an RN, LPN, home health aide, physical or occupational therapist, speech pathologist, certified physical therapy assistant or certified occupational therapy assistant.
DHS 107.11(1)(e)(e) “Initial visit” means the first home health visit of any duration in a calendar day provided by a registered nurse, licensed practical nurse, home health aide, physical or occupational therapist or speech and language pathologist for the purpose of delivering a covered home health service to a recipient.
DHS 107.11(1)(f)(f) “Subsequent visit” means each additional visit of any duration following the initial visit in a calendar day provided by an RN, LPN or home health aide for the purpose of delivering a covered home health service to a recipient.
DHS 107.11(1)(g)(g) “Unlicensed caregiver” means a home health aide or personal care worker.
DHS 107.11(2)(2)Covered home health services. Services provided by an agency certified under s. DHS 105.16 which are covered by MA are those reasonable and medically necessary services required to treat the recipient’s condition. Covered services must meet all of the following criteria:
DHS 107.11(2)(a)(a) The services are performed according to the requirements of s. DHS 105.16.
DHS 107.11(2)(b)(b) The services are provided in a place other than a hospital or nursing home.
DHS 107.11(2)(c)(c) The services provided are any of the following: